DAC-CEL T3 UPTAKE

Radioassay, Triiodothyronine Uptake

BURROUGHS WELLCOME CO.

The following data is part of a premarket notification filed by Burroughs Wellcome Co. with the FDA for Dac-cel T3 Uptake.

Pre-market Notification Details

Device IDK810212
510k NumberK810212
Device Name:DAC-CEL T3 UPTAKE
ClassificationRadioassay, Triiodothyronine Uptake
Applicant BURROUGHS WELLCOME CO. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeKHQ  
CFR Regulation Number862.1715 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1981-01-27
Decision Date1981-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.